[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global HIV & AIDS Diagnostics Market Growth (Status and Outlook) 2024-2030

May 2024 | 109 pages | ID: G41BBC57B2B0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global HIV & AIDS Diagnostics market size is projected to grow from US$ 1675.9 million in 2023 to US$ 2628.3 million in 2030; it is expected to grow at a CAGR of 6.6% from 2024 to 2030.

LPI (LP Information)' newest research report, the “HIV & AIDS Diagnostics Industry Forecast” looks at past sales and reviews total world HIV & AIDS Diagnostics sales in 2023, providing a comprehensive analysis by region and market sector of projected HIV & AIDS Diagnostics sales for 2024 through 2030. With HIV & AIDS Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV & AIDS Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global HIV & AIDS Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HIV & AIDS Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV & AIDS Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV & AIDS Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV & AIDS Diagnostics.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report presents a comprehensive overview, market shares, and growth opportunities of HIV & AIDS Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by type
  • Kits and Reagents
  • Instruments
  • Others
Segmentation by application
  • Hospitals
  • Private Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Siemens Healthineers
  • Bio-Rad
  • Abbott Laboratories
  • OraSure Technologies
  • F. Hoffmann-La Roche
  • Hologic
  • Abbott
  • Chembio Diagnostic Systems
  • Becton, Dickinson and Company
  • Danaher Corporation(Cepheid)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HIV & AIDS Diagnostics Market Size 2019-2030
  2.1.2 HIV & AIDS Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 HIV & AIDS Diagnostics Segment by Type
  2.2.1 Kits and Reagents
  2.2.2 Instruments
  2.2.3 Others
2.3 HIV & AIDS Diagnostics Market Size by Type
  2.3.1 HIV & AIDS Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
2.4 HIV & AIDS Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Private Diagnostic Laboratories
  2.4.3 Academic and Research Institutes
  2.4.4 Others
2.5 HIV & AIDS Diagnostics Market Size by Application
  2.5.1 HIV & AIDS Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)

3 HIV & AIDS DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 HIV & AIDS Diagnostics Market Size Market Share by Players
  3.1.1 Global HIV & AIDS Diagnostics Revenue by Players (2019-2024)
  3.1.2 Global HIV & AIDS Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global HIV & AIDS Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HIV & AIDS DIAGNOSTICS BY REGIONS

4.1 HIV & AIDS Diagnostics Market Size by Regions (2019-2024)
4.2 Americas HIV & AIDS Diagnostics Market Size Growth (2019-2024)
4.3 APAC HIV & AIDS Diagnostics Market Size Growth (2019-2024)
4.4 Europe HIV & AIDS Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa HIV & AIDS Diagnostics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas HIV & AIDS Diagnostics Market Size by Country (2019-2024)
5.2 Americas HIV & AIDS Diagnostics Market Size by Type (2019-2024)
5.3 Americas HIV & AIDS Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HIV & AIDS Diagnostics Market Size by Region (2019-2024)
6.2 APAC HIV & AIDS Diagnostics Market Size by Type (2019-2024)
6.3 APAC HIV & AIDS Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HIV & AIDS Diagnostics by Country (2019-2024)
7.2 Europe HIV & AIDS Diagnostics Market Size by Type (2019-2024)
7.3 Europe HIV & AIDS Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HIV & AIDS Diagnostics by Region (2019-2024)
8.2 Middle East & Africa HIV & AIDS Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa HIV & AIDS Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HIV & AIDS DIAGNOSTICS MARKET FORECAST

10.1 Global HIV & AIDS Diagnostics Forecast by Regions (2025-2030)
  10.1.1 Global HIV & AIDS Diagnostics Forecast by Regions (2025-2030)
  10.1.2 Americas HIV & AIDS Diagnostics Forecast
  10.1.3 APAC HIV & AIDS Diagnostics Forecast
  10.1.4 Europe HIV & AIDS Diagnostics Forecast
  10.1.5 Middle East & Africa HIV & AIDS Diagnostics Forecast
10.2 Americas HIV & AIDS Diagnostics Forecast by Country (2025-2030)
  10.2.1 United States HIV & AIDS Diagnostics Market Forecast
  10.2.2 Canada HIV & AIDS Diagnostics Market Forecast
  10.2.3 Mexico HIV & AIDS Diagnostics Market Forecast
  10.2.4 Brazil HIV & AIDS Diagnostics Market Forecast
10.3 APAC HIV & AIDS Diagnostics Forecast by Region (2025-2030)
  10.3.1 China HIV & AIDS Diagnostics Market Forecast
  10.3.2 Japan HIV & AIDS Diagnostics Market Forecast
  10.3.3 Korea HIV & AIDS Diagnostics Market Forecast
  10.3.4 Southeast Asia HIV & AIDS Diagnostics Market Forecast
  10.3.5 India HIV & AIDS Diagnostics Market Forecast
  10.3.6 Australia HIV & AIDS Diagnostics Market Forecast
10.4 Europe HIV & AIDS Diagnostics Forecast by Country (2025-2030)
  10.4.1 Germany HIV & AIDS Diagnostics Market Forecast
  10.4.2 France HIV & AIDS Diagnostics Market Forecast
  10.4.3 UK HIV & AIDS Diagnostics Market Forecast
  10.4.4 Italy HIV & AIDS Diagnostics Market Forecast
  10.4.5 Russia HIV & AIDS Diagnostics Market Forecast
10.5 Middle East & Africa HIV & AIDS Diagnostics Forecast by Region (2025-2030)
  10.5.1 Egypt HIV & AIDS Diagnostics Market Forecast
  10.5.2 South Africa HIV & AIDS Diagnostics Market Forecast
  10.5.3 Israel HIV & AIDS Diagnostics Market Forecast
  10.5.4 Turkey HIV & AIDS Diagnostics Market Forecast
  10.5.5 GCC Countries HIV & AIDS Diagnostics Market Forecast
10.6 Global HIV & AIDS Diagnostics Forecast by Type (2025-2030)
10.7 Global HIV & AIDS Diagnostics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Siemens Healthineers
  11.1.1 Siemens Healthineers Company Information
  11.1.2 Siemens Healthineers HIV & AIDS Diagnostics Product Offered
  11.1.3 Siemens Healthineers HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Siemens Healthineers Main Business Overview
  11.1.5 Siemens Healthineers Latest Developments
11.2 Bio-Rad
  11.2.1 Bio-Rad Company Information
  11.2.2 Bio-Rad HIV & AIDS Diagnostics Product Offered
  11.2.3 Bio-Rad HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Bio-Rad Main Business Overview
  11.2.5 Bio-Rad Latest Developments
11.3 Abbott Laboratories
  11.3.1 Abbott Laboratories Company Information
  11.3.2 Abbott Laboratories HIV & AIDS Diagnostics Product Offered
  11.3.3 Abbott Laboratories HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Abbott Laboratories Main Business Overview
  11.3.5 Abbott Laboratories Latest Developments
11.4 OraSure Technologies
  11.4.1 OraSure Technologies Company Information
  11.4.2 OraSure Technologies HIV & AIDS Diagnostics Product Offered
  11.4.3 OraSure Technologies HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 OraSure Technologies Main Business Overview
  11.4.5 OraSure Technologies Latest Developments
11.5 F. Hoffmann-La Roche
  11.5.1 F. Hoffmann-La Roche Company Information
  11.5.2 F. Hoffmann-La Roche HIV & AIDS Diagnostics Product Offered
  11.5.3 F. Hoffmann-La Roche HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 F. Hoffmann-La Roche Main Business Overview
  11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Hologic
  11.6.1 Hologic Company Information
  11.6.2 Hologic HIV & AIDS Diagnostics Product Offered
  11.6.3 Hologic HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Hologic Main Business Overview
  11.6.5 Hologic Latest Developments
11.7 Abbott
  11.7.1 Abbott Company Information
  11.7.2 Abbott HIV & AIDS Diagnostics Product Offered
  11.7.3 Abbott HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Abbott Main Business Overview
  11.7.5 Abbott Latest Developments
11.8 Chembio Diagnostic Systems
  11.8.1 Chembio Diagnostic Systems Company Information
  11.8.2 Chembio Diagnostic Systems HIV & AIDS Diagnostics Product Offered
  11.8.3 Chembio Diagnostic Systems HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Chembio Diagnostic Systems Main Business Overview
  11.8.5 Chembio Diagnostic Systems Latest Developments
11.9 Becton, Dickinson and Company
  11.9.1 Becton, Dickinson and Company Company Information
  11.9.2 Becton, Dickinson and Company HIV & AIDS Diagnostics Product Offered
  11.9.3 Becton, Dickinson and Company HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Becton, Dickinson and Company Main Business Overview
  11.9.5 Becton, Dickinson and Company Latest Developments
11.10 Danaher Corporation(Cepheid)
  11.10.1 Danaher Corporation(Cepheid) Company Information
  11.10.2 Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Product Offered
  11.10.3 Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Danaher Corporation(Cepheid) Main Business Overview
  11.10.5 Danaher Corporation(Cepheid) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. HIV & AIDS Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Kits and Reagents
Table 3. Major Players of Instruments
Table 4. Major Players of Others
Table 5. HIV & AIDS Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global HIV & AIDS Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. HIV & AIDS Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global HIV & AIDS Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global HIV & AIDS Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global HIV & AIDS Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. HIV & AIDS Diagnostics Key Players Head office and Products Offered
Table 14. HIV & AIDS Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HIV & AIDS Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global HIV & AIDS Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global HIV & AIDS Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global HIV & AIDS Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas HIV & AIDS Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas HIV & AIDS Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas HIV & AIDS Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas HIV & AIDS Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC HIV & AIDS Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC HIV & AIDS Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC HIV & AIDS Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC HIV & AIDS Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe HIV & AIDS Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe HIV & AIDS Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe HIV & AIDS Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe HIV & AIDS Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa HIV & AIDS Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa HIV & AIDS Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa HIV & AIDS Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of HIV & AIDS Diagnostics
Table 46. Key Market Challenges & Risks of HIV & AIDS Diagnostics
Table 47. Key Industry Trends of HIV & AIDS Diagnostics
Table 48. Global HIV & AIDS Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global HIV & AIDS Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global HIV & AIDS Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global HIV & AIDS Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Siemens Healthineers Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 53. Siemens Healthineers HIV & AIDS Diagnostics Product Offered
Table 54. Siemens Healthineers HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Siemens Healthineers Main Business
Table 56. Siemens Healthineers Latest Developments
Table 57. Bio-Rad Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 58. Bio-Rad HIV & AIDS Diagnostics Product Offered
Table 59. Bio-Rad Main Business
Table 60. Bio-Rad HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Bio-Rad Latest Developments
Table 62. Abbott Laboratories Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 63. Abbott Laboratories HIV & AIDS Diagnostics Product Offered
Table 64. Abbott Laboratories Main Business
Table 65. Abbott Laboratories HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Abbott Laboratories Latest Developments
Table 67. OraSure Technologies Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 68. OraSure Technologies HIV & AIDS Diagnostics Product Offered
Table 69. OraSure Technologies Main Business
Table 70. OraSure Technologies HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. OraSure Technologies Latest Developments
Table 72. F. Hoffmann-La Roche Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 73. F. Hoffmann-La Roche HIV & AIDS Diagnostics Product Offered
Table 74. F. Hoffmann-La Roche Main Business
Table 75. F. Hoffmann-La Roche HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. F. Hoffmann-La Roche Latest Developments
Table 77. Hologic Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 78. Hologic HIV & AIDS Diagnostics Product Offered
Table 79. Hologic Main Business
Table 80. Hologic HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Hologic Latest Developments
Table 82. Abbott Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 83. Abbott HIV & AIDS Diagnostics Product Offered
Table 84. Abbott Main Business
Table 85. Abbott HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Abbott Latest Developments
Table 87. Chembio Diagnostic Systems Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 88. Chembio Diagnostic Systems HIV & AIDS Diagnostics Product Offered
Table 89. Chembio Diagnostic Systems Main Business
Table 90. Chembio Diagnostic Systems HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Chembio Diagnostic Systems Latest Developments
Table 92. Becton, Dickinson and Company Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 93. Becton, Dickinson and Company HIV & AIDS Diagnostics Product Offered
Table 94. Becton, Dickinson and Company Main Business
Table 95. Becton, Dickinson and Company HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Becton, Dickinson and Company Latest Developments
Table 97. Danaher Corporation(Cepheid) Details, Company Type, HIV & AIDS Diagnostics Area Served and Its Competitors
Table 98. Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Product Offered
Table 99. Danaher Corporation(Cepheid) Main Business
Table 100. Danaher Corporation(Cepheid) HIV & AIDS Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Danaher Corporation(Cepheid) Latest Developments

LIST OF FIGURES

Figure 1. HIV & AIDS Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV & AIDS Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. HIV & AIDS Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. HIV & AIDS Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. HIV & AIDS Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global HIV & AIDS Diagnostics Market Size Market Share by Type in 2023
Figure 10. HIV & AIDS Diagnostics in Hospitals
Figure 11. Global HIV & AIDS Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. HIV & AIDS Diagnostics in Private Diagnostic Laboratories
Figure 13. Global HIV & AIDS Diagnostics Market: Private Diagnostic Laboratories (2019-2024) & ($ Millions)
Figure 14. HIV & AIDS Diagnostics in Academic and Research Institutes
Figure 15. Global HIV & AIDS Diagnostics Market: Academic and Research Institutes (2019-2024) & ($ Millions)
Figure 16. HIV & AIDS Diagnostics in Others
Figure 17. Global HIV & AIDS Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 18. Global HIV & AIDS Diagnostics Market Size Market Share by Application in 2023
Figure 19. Global HIV & AIDS Diagnostics Revenue Market Share by Player in 2023
Figure 20. Global HIV & AIDS Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas HIV & AIDS Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. APAC HIV & AIDS Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Europe HIV & AIDS Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa HIV & AIDS Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Americas HIV & AIDS Diagnostics Value Market Share by Country in 2023
Figure 26. United States HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC HIV & AIDS Diagnostics Market Size Market Share by Region in 2023
Figure 31. APAC HIV & AIDS Diagnostics Market Size Market Share by Type in 2023
Figure 32. APAC HIV & AIDS Diagnostics Market Size Market Share by Application in 2023
Figure 33. China HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe HIV & AIDS Diagnostics Market Size Market Share by Country in 2023
Figure 40. Europe HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Figure 41. Europe HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Figure 42. Germany HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa HIV & AIDS Diagnostics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country HIV & AIDS Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. APAC HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Europe HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. United States HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Canada HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. China HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Japan HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Korea HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. India HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Australia HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Germany HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. France HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. UK HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Italy HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Russia HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Spain HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Israel HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries HIV & AIDS Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Global HIV & AIDS Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global HIV & AIDS Diagnostics Market Size Market Share Forecast by Application (2025-2030)


More Publications